R

Rainier Therapeutics

2 employees

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Developer Platform
Therapeutics
Medical
Biopharma

Date founded

2021

Funding rounds raised

Total raised

$30M

from 17 investors over 17 rounds

R

Rainier Therapeutics raised $20M on May 9, 2018

Investors: Sectoral Asset Management, HealthCap, Tekla Capital Management, EQT Life Sciences, Sofinnova Ventures, Russia technology fund, Ysios Capital and Inkef

R

Rainier Therapeutics raised $30M on March 22, 2017

Investors: Ysios Capital, Sofinnova Ventures, Russia technology fund, LSP (Life Sciences Partners), Tekla Capital Management, EQT Life Sciences and HealthCap

R

Rainier Therapeutics raised $13M on January 21, 2016

Investors: Tekla Capital Management and EQT Life Sciences

R

Rainier Therapeutics raised $6M on April 2, 2014

Investors: HealthCap

R

Rainier Therapeutics raised $20M on December 28, 2012

Investors: Novo Holdings

FAQ